{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:07:00Z","timestamp":1785751620585,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:00:00Z","timestamp":1502064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T00:00:00Z","timestamp":1502064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R00 DA031767"],"award-info":[{"award-number":["R00 DA031767"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA039139"],"award-info":[{"award-number":["R21 DA039139"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA013429"],"award-info":[{"award-number":["P30 DA013429"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00213-017-4709-3","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T16:37:20Z","timestamp":1502123840000},"page":"3207-3215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of hypocretin\/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats"],"prefix":"10.1007","volume":"234","author":[{"given":"Steven J.","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Philogene-Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionya H.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor A.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Muschamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"issue":"5","key":"4709_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00213-013-3309-0","volume":"231","author":"DJ Barker","year":"2014","unstructured":"Barker DJ, Simmons SJ, Servilio LC, Bercovicz D, Ma S, Root DH et al (2014) Ultrasonic vocalizations: evidence for an affective opponent process during cocaine self-administration. Psychopharmacology 231(5):909\u2013918","journal-title":"Psychopharmacology"},{"issue":"2","key":"4709_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1570159X13999150318113642","volume":"13","author":"DJ Barker","year":"2015","unstructured":"Barker DJ, Simmons SJ, West MO (2015) Ultrasonic vocalizations as a measure of affect in preclinical models of drug abuse: a review of current findings. Curr Neuropharmacol 13(2):193\u2013210","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"4709_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF02246021","volume":"125","author":"HM Barros","year":"1996","unstructured":"Barros HM, Miczek KA (1996) Withdrawal from oral cocaine in rate: ultrasonic vocalizations and tactile startle. Psychopharmacology 125(4):379\u2013384","journal-title":"Psychopharmacology"},{"issue":"4","key":"4709_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M et al (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38(4):552\u2013562","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"4709_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/ejn.12866","volume":"41","author":"BS Bentzley","year":"2015","unstructured":"Bentzley BS, Aston-Jones G (2015) Orexin-1 receptor signaling increases motivation for cocaine-associated cues. Eur J Neurosci 41(9):1149\u20131156","journal-title":"Eur J Neurosci"},{"issue":"5","key":"4709_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0031-9384(91)90423-L","volume":"50","author":"RJ Blanchard","year":"1991","unstructured":"Blanchard RJ, Blanchard DC, Agullana R, Weiss SM (1991) Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems. Physiol Behav 50(5):967\u2013972","journal-title":"Physiol Behav"},{"key":"4709_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.neuropharm.2015.08.014","volume":"99","author":"A Blasiak","year":"2015","unstructured":"Blasiak A, Siwiec M, Grabowiecka A, Blasiak T, Czerw A, Blasiak E et al (2015) Excitatory orexinergic innervation of rat nucleus incertus\u2014implications for ascending arousal, motivation and feeding control. Neuropharmacology 99:432\u2013447","journal-title":"Neuropharmacology"},{"issue":"1","key":"4709_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","volume":"231","author":"JS Bonano","year":"2014","unstructured":"Bonano JS, Glennon RA, De Felice LJ, Banks ML, Negus SS (2014) Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats. Psychopharmacology 231(1):199\u2013207","journal-title":"Psychopharmacology"},{"issue":"36","key":"4709_CR9","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","volume":"29","author":"SL Borgland","year":"2009","unstructured":"Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB et al (2009) Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29(36):11215\u201311225","journal-title":"J Neurosci"},{"issue":"4","key":"4709_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","volume":"49","author":"SL Borgland","year":"2006","unstructured":"Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49(4):589\u2013601","journal-title":"Neuron"},{"issue":"52","key":"4709_CR11","doi-asserted-by":"publisher","first-page":"19168","DOI":"10.1073\/pnas.0507480102","volume":"102","author":"B Boutrel","year":"2005","unstructured":"Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF et al (2005) Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102(52):19168\u201319173","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4709_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bbr.2015.05.051","volume":"291","author":"ZD Brodnik","year":"2015","unstructured":"Brodnik ZD, Bernstein DL, Prince CD, Espa\u00f1a RA (2015) Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behav Brain Res 291:377\u2013384","journal-title":"Behav Brain Res"},{"issue":"3","key":"4709_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0028-3908(00)00178-7","volume":"40","author":"RE Brown","year":"2001","unstructured":"Brown RE, Sergeeva O, Eriksson KS, Haas HL (2001) Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40(3):457\u2013459","journal-title":"Neuropharmacology"},{"issue":"2","key":"4709_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-4328(94)90084-1","volume":"63","author":"SM Brudzynski","year":"1994","unstructured":"Brudzynski SM (1994) Ultrasonic vocalization induced by intracerebral carbachol in rats: localization and a dose-response study. Behav Brain Res 63(2):133\u2013143","journal-title":"Behav Brain Res"},{"issue":"2","key":"4709_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/1570159X13999150210141444","volume":"13","author":"SM Brudzynski","year":"2015","unstructured":"Brudzynski SM (2015) Pharmacology of ultrasonic vocalizations in adult rats: significance, call classification and neural substrate. Curr Neuropharmacol 13(2):180\u2013192","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"4709_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00213-013-3307-2","volume":"231","author":"CL Buck","year":"2014","unstructured":"Buck CL, Vendruscolo LF, Koob GF, George O (2014) Dopamine D1 and mu-opioid receptor antagonism blocks anticipatory 50\u00a0kHz ultrasonic vocalizations induced by palatable food cues in Wistar rats. Psychopharmacology 231(5):929\u2013937","journal-title":"Psychopharmacology"},{"issue":"4","key":"4709_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1037\/0735-7044.115.4.940","volume":"115","author":"J Burgdorf","year":"2001","unstructured":"Burgdorf J, Knutson B, Panksepp J, Ikemoto S (2001) Nucleus accumbens amphetamine microinjections unconditionally elicit 50-kHz ultrasonic vocalizations in rats. Behav Neurosci 115(4):940\u2013944","journal-title":"Behav Neurosci"},{"issue":"15","key":"4709_CR18","doi-asserted-by":"crossref","first-page":"RC89","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","volume":"20","author":"JL Cornish","year":"2000","unstructured":"Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20(15):RC89","journal-title":"J Neurosci"},{"issue":"1","key":"4709_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE et al (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95(1):322\u2013327","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"4709_CR20","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1523\/JNEUROSCI.21-23-09273.2001","volume":"21","author":"KS Eriksson","year":"2001","unstructured":"Eriksson KS, Sergeeva O, Brown RE, Haas HL (2001) Orexin\/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 21(23):9273\u20139279","journal-title":"J Neurosci"},{"issue":"2","key":"4709_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00213-010-2048-8","volume":"214","author":"RA Espa\u00f1a","year":"2011","unstructured":"Espa\u00f1a RA, Melchior JR, Roberts DC, Jones SR (2011) Hypocretin 1\/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 214(2):415\u2013426","journal-title":"Psychopharmacology"},{"issue":"2","key":"4709_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","volume":"31","author":"RA Espa\u00f1a","year":"2010","unstructured":"Espa\u00f1a RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR (2010) The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 31(2):336\u2013348","journal-title":"Eur J Neurosci"},{"issue":"2","key":"4709_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","volume":"111","author":"J Fadel","year":"2002","unstructured":"Fadel J, Deutch AY (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111(2):379\u2013387","journal-title":"Neuroscience"},{"key":"4709_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuropharm.2008.06.027","volume":"56 Suppl 1","author":"SB Flagel","year":"2009","unstructured":"Flagel SB, Akil H, Robinson TE (2009) Individual differences in the attribution of incentive salience to reward-related cues: Implications for addiction. Neuropharmacology 56 Suppl 1:139\u2013148","journal-title":"Neuropharmacology"},{"key":"4709_CR25","doi-asserted-by":"publisher","unstructured":"Gentile TA, Simmons SJ, Barker DJ, Shaw JK, Espana RA, Muschamp JW (2017) Suvorexant, an orexin\/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Addict Biol. doi:\n                    10.1111\/adb.12507","DOI":"10.1111\/adb.12507"},{"key":"4709_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","volume":"69","author":"RA Glennon","year":"2014","unstructured":"Glennon RA (2014) Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol 69:581\u2013620","journal-title":"Adv Pharmacol"},{"issue":"19","key":"4709_CR27","doi-asserted-by":"publisher","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","volume":"96","author":"JJ Hagan","year":"1999","unstructured":"Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S et al (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 96(19):10911\u201310916","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7058","key":"4709_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature04071","volume":"437","author":"GC Harris","year":"2005","unstructured":"Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437(7058):556\u2013559","journal-title":"Nature"},{"issue":"23","key":"4709_CR29","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","volume":"79","author":"WJ Herring","year":"2012","unstructured":"Herring WJ, Snyder E, Budd K, Hutzelmann J, Snavely D, Liu K et al (2012) Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 79(23):2265\u20132274","journal-title":"Neurology"},{"key":"4709_CR30","doi-asserted-by":"publisher","unstructured":"Hicks C, Gregg RA, Nayak SU, Cannella LA, Schena GJ, Tallarida CS, ..., et al.. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Psychopharmacology (Berl) 2017;In Press. \n                    10.1007\/s00213-017-4568-y","DOI":"10.1007\/s00213-017-4568-y"},{"issue":"5","key":"4709_CR31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1017\/S1461145711000423","volume":"14","author":"MH James","year":"2011","unstructured":"James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, Smith DW et al (2011) Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 14(5):684\u2013690","journal-title":"Int J Neuropsychopharmacol"},{"key":"4709_CR32","doi-asserted-by":"publisher","unstructured":"James MH, Mahler SV, Moorman DE, Aston-Jones G (2016) A decade of orexin\/hypocretin and addiction: where are we now? Curr Top Behav Neurosci. doi:\n                    10.1007\/7854_2016_57","DOI":"10.1007\/7854_2016_57"},{"issue":"1","key":"4709_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbr.2010.04.057","volume":"214","author":"EY Maier","year":"2010","unstructured":"Maier EY, Ahrens AM, Ma ST, Schallert T, Duvauchelle CL (2010) Cocaine deprivation effect: cue abstinence over weekends boosts anticipatory 50-kHz ultrasonic vocalizations in rats. Behav Brain Res 214(1):75\u201379","journal-title":"Behav Brain Res"},{"issue":"1","key":"4709_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/cne.1190","volume":"435","author":"JN Marcus","year":"2001","unstructured":"Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M et al (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435(1):6\u201325","journal-title":"J Comp Neurol"},{"key":"4709_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213","journal-title":"Neuropharmacology"},{"issue":"4","key":"4709_CR36","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00213-011-2429-7","volume":"219","author":"PJ Meyer","year":"2012","unstructured":"Meyer PJ, Ma ST, Robinson TE (2012) A cocaine cue is more preferred and evokes more frequency-modulated 50-kHz ultrasonic vocalizations in rats prone to attribute incentive salience to a food cue. Psychopharmacology 219(4):999\u20131009","journal-title":"Psychopharmacology"},{"issue":"11","key":"4709_CR37","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1523\/JNEUROSCI.4121-06.2007","volume":"27","author":"JW Muschamp","year":"2007","unstructured":"Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM (2007) A role for hypocretin (orexin) in male sexual behavior. J Neurosci 27(11):2837\u20132845","journal-title":"J Neurosci"},{"issue":"16","key":"4709_CR38","doi-asserted-by":"publisher","first-page":"E1648","DOI":"10.1073\/pnas.1315542111","volume":"111","author":"JW Muschamp","year":"2014","unstructured":"Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S et al (2014) Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc Natl Acad Sci U S A 111(16):E1648\u2013E1655","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4709_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s002130050497","volume":"135","author":"NH Mutschler","year":"1998","unstructured":"Mutschler NH, Miczek KA (1998) Withdrawal from i.v. cocaine \u201cbinges\u201d in rats: ultrasonic distress calls and startle. Psychopharmacology 135(2):161\u2013168","journal-title":"Psychopharmacology"},{"key":"4709_CR40","doi-asserted-by":"publisher","unstructured":"Nguyen JD, Aarde SM, Cole M, Vandewater SA, Grant Y and Taffe MA. Locomotor stimulant and rewarding effects of inhaling methamphetamine, MDPV, and mephedrone via electronic cigarette-type technology. Neuropsychopharmacology. 2016;In Press. doi:\n                    10.1038\/npp.2016.88","DOI":"10.1038\/npp.2016.88"},{"issue":"9197","key":"4709_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355(9197):39\u201340","journal-title":"Lancet"},{"issue":"5","key":"4709_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.genhosppsych.2011.05.014","volume":"33","author":"TM Penders","year":"2011","unstructured":"Penders TM, Gestring R (2011) Hallucinatory delirium following use of MDPV: \u201cbath salts\u201d. Gen Hosp Psychiatry 33(5):525\u2013526","journal-title":"Gen Hosp Psychiatry"},{"issue":"23","key":"4709_CR43","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG et al (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18(23):9996\u201310015","journal-title":"J Neurosci"},{"issue":"1","key":"4709_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1021\/cn500246j","volume":"6","author":"CD Prince","year":"2015","unstructured":"Prince CD, Rau AR, Yorgason JT, Espa\u00f1a RA (2015) Hypocretin\/orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. ACS Chem Neurosci 6(1):138\u2013146","journal-title":"ACS Chem Neurosci"},{"key":"4709_CR45","doi-asserted-by":"crossref","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, ..., et al.. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(5):1 page following 696","DOI":"10.1016\/S0092-8674(00)80949-6"},{"key":"4709_CR46","doi-asserted-by":"crossref","unstructured":"Scardochio T, Trujillo-Pisanty I, Conover K, Shizgal P and Clarke PB. The effects of electrical and optical stimulation of midbrain dopaminergic neurons on rat 50-kHz ultrasonic vocalizations. Front Behav Neurosci. 2015;9(331)","DOI":"10.3389\/fnbeh.2015.00331"},{"issue":"10","key":"4709_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","volume":"233","author":"CW Schindler","year":"2016","unstructured":"Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, Brandt SD et al (2016) Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233(10):1981\u20131990","journal-title":"Psychopharmacology"},{"key":"4709_CR48","doi-asserted-by":"publisher","unstructured":"Simmons SJ, Gregg RA, Tran FH, Mo L, von Weltin E, Barker DJ, ..., et al.. Comparing rewarding and reinforcing properties between \u2018bath salt\u2019 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats. Addict Biol. 2016;In Press. doi:\n                    10.1111\/adb.12479","DOI":"10.1111\/adb.12479"},{"issue":"1","key":"4709_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuropharm.2009.06.042","volume":"58","author":"RJ Smith","year":"2010","unstructured":"Smith RJ, Tahsili-Fahadan P, Aston-Jones G (2010) Orexin\/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 58(1):179\u2013184","journal-title":"Neuropharmacology"},{"issue":"6","key":"4709_CR50","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States. Clin Toxicol (Phila) 49(6):499\u2013505","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"4709_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1037\/bne0000184","volume":"131","author":"JO Taylor","year":"2017","unstructured":"Taylor JO, Urbano CM, Cooper BG (2017) Differential patterns of constant frequency 50 and 22\u00a0kHz USV production are related to intensity of negative affective state. Behav Neurosci 131(1):115\u2013126","journal-title":"Behav Neurosci"},{"issue":"3","key":"4709_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1037\/0735-7036.97.3.201","volume":"97","author":"DA Thomas","year":"1983","unstructured":"Thomas DA, Takahashi LK, Barfield RJ (1983) Analysis of ultrasonic vocalizations emitted by intruders during aggressive encounters among rats (Rattus norvegicus). J Comp Psychol 97(3):201\u2013206","journal-title":"J Comp Psychol"},{"issue":"2","key":"4709_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","volume":"19","author":"LR Watterson","year":"2014","unstructured":"Watterson LR, Kufahl PR, Nemirovsky NE, Sewalia K, Grabenauer M, Thomas BF et al (2014) Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV). Addict Biol 19(2):165\u2013174","journal-title":"Addict Biol"},{"issue":"4","key":"4709_CR54","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00213-012-2871-1","volume":"225","author":"JM Wright","year":"2013","unstructured":"Wright JM, Dobosiewicz MR, Clarke PB (2013) The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations. Psychopharmacology 225(4):853\u2013868","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4709-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4709-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:08:06Z","timestamp":1589620086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4709-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":54,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4709"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4709-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]},"assertion":[{"value":"12 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding disclosures"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}